{'fraction_non_alphanumeric': 0.04008667388949079, 'fraction_numerical': 0.035752979414951244, 'mean_word_length': 4.6, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
role of Apelin, Adipsin and C-reactive protein in patients with chronic kidney disease

Chronic kidney disease (CKD) is a growing global health problem. The adipose tissue may directly affect the kidney through its activity as an endocrine gland through the secretion of adipokines. This study was a cross sectional which conducted in Kirkuk city for the period from June 2020 to September 2021.study population age ranged from (30 – 90) years old. The total of 80 subjects was separated to two groups as following: Kidney failure group: 65 patients and control group: 15 patients. The results referred to the increased levels of Apelin, Adipsin and C reactive protein (CRP) in CKD with highly significant differences (P≤0.01) when compared with control group, also a positive correlation was found between Adipsin and Apelin in the second stage (r = 0.742) , the third stage (r = 0.573) and in the fifth stage (r = 0.552).